Aberrant expression of NUAK1 has been observed in patients diagnosed with multiple cancer types including prostate cancer [9], nasopharyngeal carcinoma [10], pancreatic cancer [11] and colorectal cancer [12]. This evidence concerns the gene NUAK1 and familial pancreatic carcinoma.